Natera Inc Total Assets
Natera Inc total assets. Based on the latest financial reports, Natera Inc (NTRA) holds total assets worth $2.66 Billion USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is Natera Inc worth for the company's overall valuation and market capitalisation.
Total Assets of Natera Inc (2012–2025)
Total assets of Natera Inc from 2012 to 2025. This chart illustrates how Natera Inc's total assets have evolved over time, based on quarterly financial data. See Natera Inc stock quote for real-time trading data and today's change.
Natera Inc - Asset Composition Analysis
Natera Inc Total Assets Breakdown (December 2025)
Natera Inc total assets breakdown as of December 2025. Natera Inc's total assets of $2.66 Billion consist of 59.7% current assets and 40.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 42.9% |
| Accounts Receivable | $296.53 Million | 11.8% |
| Inventory | $68.44 Million | 2.7% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $373.71 Million | 14.9% |
| Goodwill | $141.07 Million | 5.6% |
Asset Composition Trend (2012–2025)
This chart illustrates how Natera Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Natera Inc (NTRA) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Natera Inc's current assets represent 59.7% of total assets in 2025, a decrease from 67.8% in 2012.
- Cash Position: Cash and equivalents constituted 42.9% of total assets in 2025, down from 43.4% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 19.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is intangible assets at 14.9% of total assets.
Natera Inc Competitors by Total Assets
Key competitors of Natera Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.00 Billion |
|
Hangzhou Tigermed Consulting
SHE:300347
|
China | CN¥28.80 Billion |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
China | CN¥1.42 Billion |
|
SMO ClinPlus Co. Ltd.
SHE:301257
|
China | CN¥1.52 Billion |
|
Eurofins-Cerep SA
PA:ALECR
|
France | €88.84 Million |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
Natera Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.00 | 3.72 | 5.96 |
| Quick Ratio | 2.85 | 3.58 | 5.82 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $1.11 Billion | $1.05 Billion | $991.51 Million |
Natera Inc - Advanced Valuation Insights
This section examines the relationship between Natera Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 30.93 |
| Latest Market Cap to Assets Ratio | 17.93 |
| Asset Growth Rate (YoY) | 51.0% |
| Total Assets | $2.51 Billion |
| Market Capitalization | $44.97 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Natera Inc's assets at a significant premium (17.93x), suggesting investors see substantial growth potential or unique competitive advantages.
Rapid Asset Growth: Natera Inc's assets grew by 51.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Natera Inc (2012–2025)
The table below shows the annual total assets of Natera Inc from 2012 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $2.51 Billion | +51.02% |
| 2024-12-31 | $1.66 Billion | +15.19% |
| 2023-12-31 | $1.44 Billion | +3.39% |
| 2022-12-31 | $1.39 Billion | +12.78% |
| 2021-12-31 | $1.24 Billion | +32.65% |
| 2020-12-31 | $932.15 Million | +59.98% |
| 2019-12-31 | $582.66 Million | +117.27% |
| 2018-12-31 | $268.17 Million | +24.96% |
| 2017-12-31 | $214.61 Million | +1.87% |
| 2016-12-31 | $210.68 Million | -20.57% |
| 2015-12-31 | $265.24 Million | +114.56% |
| 2014-12-31 | $123.62 Million | +106.99% |
| 2013-12-31 | $59.72 Million | +349.28% |
| 2012-12-31 | $13.29 Million | -- |
About Natera Inc
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehe… Read more